Diagnostic advances in infectious diseases encompass the development and implementation of innovative technologies and methodologies that improve the speed, accuracy, and accessibility of identifying pathogens. These advancements support timely treatment, outbreak containment, antimicrobial stewardship, and overall patient management.
Accurate and rapid diagnostics are the cornerstone of infectious disease control, influencing everything from individual care decisions to global outbreak response. This session will explore the latest diagnostic technologies, including molecular methods, point-of-care devices, biosensors, artificial intelligence, and omics-based platforms that are transforming the field of infectious disease diagnostics.
Key focus areas include:
- Point-of-care and rapid diagnostic tests (RDTs)
- Next-generation sequencing (NGS) and metagenomics in pathogen detection
- AI-driven diagnostics and decision-support tools
- CRISPR-based diagnostics (e.g., SHERLOCK, DETECTR)
- Diagnostic stewardship in antimicrobial resistance (AMR) control
- Integration of diagnostics in pandemic preparedness and One Health
- Accessibility of diagnostics in low- and middle-income countries
This session invites clinicians, microbiologists, biomedical engineers, public health professionals, and diagnostics industry leaders to discuss cutting-edge tools that are reshaping disease detection, surveillance, and global health interventions.